Does Paxlovid reduce long COVID symptoms? Yale-led trial finds out Dr. Kamal Kant Kohli8 April 2025 9:00 PM ISTAntiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving long COVID symptoms, according to a new study published in The...
Paxlovid may reduce all-cause mortality in pediatric patients with SARS-CoV-2 infection: Study Jacinthlyn Sylvia17 Jun 2024 9:30 AM ISTA recent study published in the Nature Communications addressed the significant gap in data regarding the use of the antiviral combination...
Is Paxlovid treatment for Covid-19 effective? Study finds answers Isra Zaman3 Nov 2023 9:15 AM ISTA retrospective target trial emulation study has found that Nirmatrelvir-ritonavir treatment for COVID-19 showed limited effectiveness in preventing...
Medical Bulletin 2/October/2023 Isra Zaman2 Oct 2023 3:15 PM ISTHere are the top medical news of the day:FDA approves Depression drug after rejecting it multiple times in 20 years Gepirone hydrochloride...
Researchers find Ritomavir boosted Nirmatrelvir outperforms Molnupiravir in early COVID 19 treatment Isra Zaman2 Oct 2023 9:00 AM ISTIn an ongoing international study published in The Lancet Infectious Diseases , researchers have found that both molnupiravir and ritonavir-boosted...
FDA Approves Paxlovid as first Oral Antiviral for Treating COVID-19 in Adults Dr. Kamal Kant Kohli29 May 2023 11:00 AM ISTThe U.S. Food and Drug Administration has approved first Oral Antiviral for Treating COVID-19 in Adults.Paxlovid is the fourth drug-and first oral...
Nirmatrelvir reduces likelihood of development of long COVID when given in 1st week of infection Jacinthlyn Sylvia27 March 2023 8:00 PM ISTA new study by Yan Xie and team showed that intervention with nirmatrelvir within five days of a positive SARS-CoV-2 test was linked to a reduced...
Paxlovid reduces COVID-19 severity by 79 % to 89 % when given in first five days of testing positive Aditi22 March 2023 11:00 AM ISTUSA: An original investigation on Infectious diseases published in the Lancet has addressed the effectiveness of vaccination in preventing the...
FIRST: Hetero wins WHO Prequalification for generic version of Pfizer COVID drug Paxlovid Ruchika Sharma26 Dec 2022 4:15 PM ISTThe combi pack, launched by Hetero as NIRMACOM, will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet).
Medical Bulletin 16/December/2022 Isra Zaman16 Dec 2022 2:30 PM ISTHere are the top medical news for the day:Antibiotic resistance may be overcome by mapping E.coliHave you ever felt queasy after eating an undercooked...
Antiviral drug nirmatrelvir plus ritonavir effective in reducing COVID-19 hospitalization among vaccinated adults 50 and over Isra Zaman16 Dec 2022 9:30 AM ISTThe results of recent clinical trial, now published in Annals of Internal Medicine, suggest that the antiviral drug nirmatrelvir plus ritonavir...
COVID drug: Zenara Pharma unveils generic of Pfizer Paxlovid at Rs 5,200 per box in India Ruchika Sharma10 Sept 2022 9:30 AM ISTThe tablet which will be sold under the brand name Paxzen.
